Affymax, Inc. (NASDAQ:AFFY)

CAPS Rating: 2 out of 5

The Company is a biopharmaceutical company developing novel peptide-based drug candidates to improve the treatment of serious and often life-threatening conditions.

Recs

2
Player Avatar acts20 (39.57) Submitted: 12/7/2011 5:31:28 PM : Outperform Start Price: $7.40 AFFY Score: +87.30

Wish I would't have sold 30% of my shares. Hope to see $12 in a month

Featured Broker Partners


Advertisement